Our analysis of patient overall survival revealed that low SIRT7 mRNA levels correlate with worse overall survival in 60% of patients, suggesting a potential tumor suppressor role of SIRT7 in this type of tumors, regardless of p53 status (Figure 3A). Here, TP53 is linked to neoplasm.